As mentioned earlier, Llurba et al. [10] reported an imbalance in the sFlt-1 (soluble fms-like tyrosine kinase 1) and placental like growth factor (PlGF) levels in pregnant women carrying fetuses with CHD–a recognised finding in fetal growth restriction [25]. This evidence concerns the gene PGF and fetal growth restriction.